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Background
Cholangiocarcinoma is a malignant tumor arising from the epithelium of the bile ducts. Most of these tumors are adenocar­
cinomas [1]. Intrahepatic cholangiocarcinoma accounts for 10% of all cholangiocarcinomas, hilar cholangiocarcinoma for 
25%, and extrahepatic cholangiocarcinoma for 65% [2, 3]. Cholangiocarcinoma can develop in any part of the extrahepatic 
duct, occurring in 50–75% of reported cases in the upper third of the duct including the hepatic hilum, in 10–25% in the 
middle third, and in 10–20% in the lower third [4–6]. Approximately 95% of cases show extrahepatic obstruction at the time 
of diagnosis [7]. In a meta­analysis of 21 prospective trials, the rate of hemorrhage as a complication of ERCP was 1.3% (95% 
CI, 1.2%–1.5%) with 70% of the bleeding episodes classified as mild [8]. Hemorrhagic complications may be immediate or 
delayed, with recognition of occurring up to 2 weeks after the procedure. The risk of severe hemorrhage (ie, requiring >5 units 
of blood, surgery or angiography) is estimated to occur in fewer than1 per 1 000 sphincterotomies [9]. Despite new and ad­
vanced diagnostic methods, sometimes this type of tumor is finally diagnosed from pathological findings on excised tissue. 
Case report
We present one case with cholangiocarcinoma diagnosed after surgical treatment of hemorrhage as post procedural compli­
cation from ERCP.  With MRCP intraluminal stenosis of the upper part of common bile duct has been noticed and suspicious 
presence of substrate with consecutive dilatation of the upper billiary tract. ERCP was performed and sphincterotomy have 
been made without evacuation of any intraluminal substrate from common bile duct. Insufficient ERCP cholangiography was 
made and biopsy of the part with stenosis could not be taken due to permanent bleeding from performed sphincterotomy. 
Despite all attempts for conservative treatment of the hemorrhage, patient was still with permanent decreases of hemoglo­
bin levels and with persistent hemorrhagic anemia. With decision from medical council the patient has been transferred to 
the Department of abdominal surgery for further immediate surgical treatment.
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Conclusion
Patient with extrahepatic bile duct carcinoma initially diagnosed as a calculus in the common bile duct. Looking back, the pa­
tient had symptoms which differential diagnosis for bile duct cholangiocarcinoma should be established. Clinical symptoms 
such as right hypochondrium pain, itchy skin, vomiting and diarrhea. The laboratory findings showed constantly elevated 
bilirubin and liver enzymes also elevated tumor markers as CA19­9 and CEA. 
Hemorrhage that occurs after ERCP sphincterotomy and attempt for biopsy could not been controlled with conservative 
measures.
Patient with consequently caused hemorrhagic anemia has been transferred for surgical treatment, which stopped the bleed­
ing, made final diagnosis and treatment of proximal stenosis of common bile duct.
Key words: cholangiocarcinoma, ERCP hemorrhage, billiary stenosis. 
ERCP as it is a non-invasive modality [15, 16]. When 
US shows intraductal tumor, initial ERCP rather than 
MRCP should be carried out for cost-effectiveness, 
even if the patient shows no jaundice. However, when 
US show only dilatation of the extrahepatic bile duct, 
MRCP is a safe modality to obtain a clear cholangio-
gram. On ERCP or MRCP findings, benign diseases 
including post-operative stenosis, chronic pancreatitis, 
primary sclerosing cholangitis, or autoimmune pancre-
atitis show bile duct stenosis as well as malignant disease 
[17–19]. Cholangiography shows filling defects at the 
common bile duct in patients with adenomyoma [17] 
or inflammatory strictures [18]. Therefore, accurate 
distinction between benign and malignant biliary struc-
tures is essential to avoid unnecessary surgery. The ac-
curacy of MRCP is comparable with that of ERCP[19]. 
Malignancy is suggested when cholangiography shows 
long (greater than 10 mm), asymmetric, and irregular 
strictures. Benign disease is suggested when cholangi-
ography shows short, regular, and symmetric strictures. 
Using these criteria, the diagnostic sensitivity and speci-
ficity for ERCP were 74% and 70%, respectively. The 
diagnostic sensitivity and specificity for MRCP were 
70% and 72%, respectively [19]. 
Accurate diagnosis of the extent of the cancer is es-
sential to enable selection of the appropriate medical 
and surgical therapy [13]. 
On dynamic CT findings, extrahepatic cholangiocar-
cinoma may be seen as a focal thickening of the ductal 
wall with various enhancement patterns. Until now, in 
many cases of extrahepatic cholangiocarcinoma, visu-
alization of the tumor was not definitive because they 
were too small to be detected [12, 16, 20–31]. Extra-
hepatic bile duct carcinoma shows longitudinal spread 
Introduction
Most patients with bile duct cancer are diagnosed in an 
advanced stage [10–12]. 
To improve the therapeutic effect of bile duct carci-
noma, efforts have been focused on diverse areas: early 
detection of the lesions, accurate differentiation of be-
nign and malignant biliary stenosis, and assessment of 
loco regional tumor extension, development of surgical 
methods, biliary stenting, and chemo radiotherapy for 
unresectable bile duct cancer [13]. 
In the diagnosis of intrahepatic cholangiocarcinoma, 
non-invasive, cross-sectional imaging tests including 
computed tomography (CT) and magnetic resonance 
imaging (MRI) are useful [13]. 
MRI in the form of magnetic resonance cholangio-
pancreatography (MRCP) and multi-detector low CT 
(MDCT) are the most commonly performed imaging 
tests in these patients. In contrast, for the diagnosis of 
extrahepatic bile duct cancer, an endoscopic approach 
is essential, for the simple reason that endoscopic tech-
niques are more invasive and include the use of endo-
scopic retrograde cholangiopancreatography (ERCP) 
and endoscopic ultrasonography (EUS) [13]. In the 
middle and distal bile duct, ultrasonography (US) can-
not assess tumors sufciently due to disturbance by 
gastrointestinal gas [14]. 
Even now, the sensitivities of US in demonstrating 
hilar tumor, middle bile duct tumor, and distal bile 
duct tumor are 85.6%, 59.1%, and 33.3%, respectively 
[14]. Therefore, bile duct dilatation on US findings is an 
important sign for the early diagnosis of bile duct cancer 
[14]. Until recently, when US showed dilatation of the 
bile duct, ERCP was the next step to obtain cholangi-
ography. Recently, MRCP has become an alternative to 
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along the bile duct, often resulting in residual tumor 
at the surgical margin [13]. The length of longitudinal 
extension is determined by the type of invasion, with 
a mean length of 6–10 mm for the submucosal spread 
and 10–20 mm for the mucosal spread [34, 35]. MDCT 
correctly revealed longitudinal extension of extrahepatic 
cholangiocarcinoma in 62.5%–78.6% of patients [36, 
37]. However, CT has a strong tendency to underesti-
mate longitudinal mucosal spread, which is common in 
extrahepatic cholangiocarcinoma [38–46].  Tompkins 
et al [10] reported that 91% of patients with bile duct 
cancer who underwent surgery had serum bilirubin 
levels greater than 2.0 mg/dL. This is a case presenta-
tion about a female patient initially considered to have 
calculus, turned out to have cholangiocarcinoma in the 
common bile duct.
Case presentation 
Female patient, aged 61, had diarrhea and was vomiting 
for two weeks. She had moderate to severe pain in the 
epigastrium and right hypochondrium.
She vomited only gastric contents several times, no 
blood or mucus was presented in her stool either. She 
also started to feel itchy, and her skin became more 
sensitive than usual. She consulted her general physi-
cian, who scheduled ultrasound of the abdomen and 
appointed laboratory tests.
Laboratory findings
Aspartat aminotransferase (AST) – 885 U/L, alanine 
aminotransferase (ALP) – 768 U/L, alkaline phospha-
tase (ALP) – 456 U/L, gamma glutamyl transferase 
(GGT) – 2 098 U/L, total bilirubin – 64 umol/L, direct 
bilirubin – 55 umol/L.
Ultrasound findings
Ultrasound of the abdomen showed that the gall 
bladder was with hyper echoic and thickened walls 
up to 4–5 mm, and the walls were in layers towards 
the fundus, without detectable calculus in the lumen. 
Furthermore, the ultrasound showed that common bile 
duct (ductus choledochus) was dilatated up to 12 mm 
in diameter, without ultrasound detectable intraluminal 
defect, while the intrahepatic biliary stem was empha-
sized and initially dilated.
Because of the fore mentioned ultrasound finding 
and laboratory results, the patient was hospitalized with 
a working diagnosis for calculus in the common bile 
duct, for additional investigations and treatment, at the 
Intensive care and emergency medicine department at 
the City General Hospital (8th of September) in Skopje. 
Physical exam
Without deviations in the review of systems, with 
the exception of the pale yellow colored skin (her sclera 
was also yellow), and pain on palpation in right hypo-
chondrium.
Other investigations
During her hospitalization, many laboratory tests and 
interventions were performed, as protocol requires. Her 
electrocardiogram (ECG) was unremarkable. Her total 
bilirubin, direct bilirubin, as well as the transaminases 
were all significantly elevated. Another ultrasound of the 
abdomen was performed. 
The ultrasound showed an iso-echoic and homoge-
neous liver, with expected size and shape, with present 
intrahepatic dilatation of the biliary tract, without fo-
cal defects. The gall bladder had thickened walls, but 
without calculus in the lumen. The common bile duct 
(ductus choledochus) was dilated up to 16 mm, and had 
thickened walls as well. In the visible part calculus has 
not been noted.
However the pre-papillary region was unavailable for 
ultrasound assessment and therefore no final conclusion 
was made. The pancreas was non-homogeneous in the 
area of its head, while the rest of the gland was without 
alteration. Other findings on the abdominal organs were 
without clinical significances. 
No free fluid was detected in the abdomen.
Additionally serum analysis for CA 19–9 and CEA 
tumor markers has been made.
CA 19–9 – 51,5 U/ml and CEA – 7,2 ng/ml.
These findings were still inconclusive, so the doctors 
decided to perform magnetic resonance imaging (MRI) 
of the abdomen with (MRCP) magnetic resonance chol-
angiopancreatography.
MRCP 
The finding clearly presented an enlarged head of the 
pancreas, with no restriction to diffusion. In addition, 
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there was a reduction of the lumen of the upper part of 
common bile duct and high presence of the substrate 
with consecutive dilatation of the common bile duct, 
and the hepatic duct to the right and to the left as well, 
with a maximum measured diameter of 15 mm. (Fig-
ure 1 and 2).
Further evaluation with endoscopic retrograde chol-
angiopancreatography (ERCP) was recommended.
ERCP
ERCP was performed and sphincterotomy have been 
made without evacuation of any intraluminal substrate 
from common bile duct.
Insufcient ERCP cholangiography was made and 
biopsy of the part with stenosis could not be taken due 
to permanent bleeding from performed sphincterotomy.
We do not have data for any intervention performed 
for treatment of bleeding during this procedure.
Because hemorrhage has been occurred during medi-
cal procedure, additional test has been performed.
Hematology findings
Hb – 75 g/L; Hct – 22.4%; RBC – 3.10x1012/L; 
WBC – 12.3x109/L; PLT – 193x109/L.
Coagulation tests
Prothrombin time (PT) – 16.1 second, activated 
partial thromboplastin time (aPTT) – 44 seconds, in-
ternational normalized ratio (INR) – 1.3.
Figure 1. Figure 2.
Patient without history of any anticoagulant and 
antiagregation medication intake
Laboratory tests
Aspartat aminotransferase (AST) – 435 U/L, alanine 
aminotransferase (ALP) – 368 U/L, alkaline phospha-
tase (ALP) – 246 U/L, gamma glutamyl transferase 
(GGT) – 798 U/L, total bilirubin – 55 umol/L, direct 
bilirubin – 43 umol/L.
Specialist in transfusion medicine was consulted and 
therapy with two units of FFP (fresh frozen plasma) was 
administered, also with 1 Erythrocyte concentrate unit 
(350 ml) and therapy with Vitamin K intravenously 
have been started.
Twelve days after hospital admission and one day 
after ERCP, patient was still slightly anemic with con-
tinuous decreasing of hemoglobin, erythrocyte count 
and hematocrit. Coagulation test were normalized.
Patient report two black stools, one day after ERCP 
was performed.
Administration of one erythrocyte concentrate unit 
(350 ml), FFP and therapy with colloids and crystalloid 
solution have been continued. 
Medical consilium from gastroenterohepathologist, 
general surgeon and transfusiologist have been held 
second day after ERCP.
A decision was made and patient for further surgi-
cal treatment was transferred to the Department of 
abdominal surgery in CGH 8th September in order 
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to get surgical treatment for the bleeding from ductus 
choledochus, which caused the anemia in the first place. 
Another reason for transferring the patient to the surgi-
cal department however, was the fact that the imaging 
showed a suspicious stenosis at the proximal part of the 
common bile duct (ductus choledochus).
Surgical procedure
After all the pre-surgical preparations were made the 
patient was operated in general anesthesia. Intraopera-
tive, by ligation and resection of the cystic artery and 
the cystic duct anterograde cholecystectomy was first 
performed. 
The next step was mobilization of the common bile 
duct (ductus choledochus), after which in its proximal 
part a mass forming tumorous formation was observed. 
The tumor formation of the common bile duct (ductus 
choledochus) occupied 2/3 of the circumference of 
the wall, in total length of 1 cm. During the surgery, 
a decision was made to continue with supraduodenal 
resection of common bile duct, after prior ligation of 
the inbred vessels. 
Intraluminally in common bile duct thrombotic 
masses were observed.
The fatty pillow from hepatoduodenal ligament and 
hepatic hilus has been removed without macroscopic 
enlarged lymph nodes.
The jejunal loop was mobilized and a terminal-lateral 
(T-L) anastomosis of the distal end was formed with the 
common hepatic duct with the jejunum, followed by an 
entero-entero anastomosis (EEA) according to Braun. 
The postoperative course of the patient went smooth-
ly, with established intestinal peristalsis and passage, as 
well as oral feeding. 
The pathohistology finding was – Cholangiocarcino-
ma of the common bile duct in its proximal part (Latin: 
cholangoracinoma ducti choledochi partis proximalis). 
Tumor was in Stage I according to pTNM classification. 
The patient, as per protocol, was referred to the 
University Clinic of radiotherapy and oncology, for 
adjuvant therapy.
Discussion
Preoperative evaluation of bile duct cancer in terms of 
radical resection consists of a multidisciplinary approach 
with ultrasonography (US), helical-computed tomogra-
phy, magnetic resonance imaging (MRI) including MR 
cholangiopancreatography (MRCP), direct cholangiog-
raphy via endoscopic retrograde cholangiography (ERC) 
or percutaneous transhepatic biliary drainage (PTBD), 
intra-ductal US (IDUS), and bile cytology or biopsy [47]. 
Several advances have been made in the surgical 
management of bile duct cancer within the last two 
decades. Surgical morbidity and mortality have been 
dramatically decreased, but the long-term outcome 
remains poor [48]. 
Complete surgical resection with a microscopically 
negative margin is the only factor under the control of 
the surgeon and is therefore the most important goal of 
surgical treatment [48]. 
A recent study emphasized the significance and ac-
curacy of intraoperative assessment of bile duct margin 
[50], while a positive bile duct margin itself seems to 
have minimum impact on patient survival [51–53]. 
As noted above, there is a close association between 
the extent of the hepatic resection and the rate of nega-
tive margins in hilar cholangiocarcinoma [54]. These 
factors all warrant an aggressive surgical approach to 
bile duct cancer. Because of the high rate of recurrence 
and poor survival after radical surgery, postoperative 
chemotherapy, radiotherapy, and chemo-radiation have 
been evaluated in terms of improving patient survival 
after resection of bile duct cancer [49].
Conclusion
Patient with extrahepatic bile duct carcinoma initially 
diagnosed as a calculus in the common bile duct. Looking 
back, the patient had symptoms which differential diagno-
sis for bile duct cholangiocarcinoma should be established. 
Clinical symptoms such as right hypochondrium pain, 
itchy skin, vomiting and diarrhea. The laboratory findings 
showed constantly elevated bilirubin and liver enzymes 
also elevated tumor markers as CA19-9 and CEA. 
Hemorrhage that occurs after ERCP sphincterotomy 
and attempt for biopsy could not been controlled with 
conservative measures.
Patient with consequently caused hemorrhagic ane-
mia has been transferred for surgical treatment, which 
stops the bleeding and made final diagnosis and treat-
ment of proximal stenosis of common bile duct.
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